Nasal Nanodrops Show Breakthrough Potential Against Deadly Brain Tumors
Researchers have developed a nasal nanodrop therapy that may transform future brain cancer treatment. The method delivers tiny, gold-based particles through the nose. These particles activate the brain’s immune system and help target glioblastoma, a fast-growing and hard-to-treat tumor. As a result, the treatment avoids surgery and reduces stress for patients.
Why Glioblastoma Remains a Challenge
Glioblastoma grows quickly and often evades detection. It affects thousands of people each year and remains difficult to treat. Traditional medicines struggle to cross the blood-brain barrier. However, this new approach uses spherical nucleic acids that enter the brain safely and activate the STING pathway, a key immune defense.
Turning “Cold Tumors” Into Targets
Glioblastoma is known as a “cold tumor” because it does not trigger a strong immune response. The new nanodrops help change that behavior. They carry short DNA fragments that turn on the STING pathway. In addition, they travel along a natural nerve pathway from the nose to the brain, which reduces the risk of unwanted side effects.
How the Treatment Works in Mice
Researchers tested the therapy on mice with glioblastoma. They tracked the particles using a glowing molecular tag. The nanodrops reached the tumor and activated immune cells in the area. When combined with T-cell-boosting drugs, the treatment cleared the tumors. It also prevented them from returning, which shows strong long-term potential.
A Step Toward Future Care
The team hopes to expand the therapy by adding more immune-activating features. Therefore, this approach could support safer and more effective treatments for other hard-to-treat cancers. While more studies are needed, the findings open a promising new direction for cancer immunotherapy.
